Action Alert: Voluntary Withdrawal of IVIG Product

As part of HFA’s ongoing mission to assist and advocate for the bleeding disorders community, this action alert is being issued to keep you informed about blood safety.About This WithdrawalDue to increased reports of hypersensitivity reactions such as rashes or urticaria and/or wheezing, Octapharma USA Inc. has voluntarily withdrawn from the market one lot of IVIG medication […]

en_USEnglish